Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer

Objective: To estimate differences in the economic valuation and sociodemographic and clinical factors associated with informal care between phases of the treatment in the case of blood cancer patients. Methods: 139 haematological cancer patients who underwent a stem cell transplantation completed a...

Full description

Bibliographic Details
Main Authors: Marta Ortega-Ortega, Roberto Montero-Granados, Juan de Dios Jiménez-Aguilera
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Gaceta Sanitaria
Online Access:http://www.sciencedirect.com/science/article/pii/S0213911117300948
_version_ 1819194686871437312
author Marta Ortega-Ortega
Roberto Montero-Granados
Juan de Dios Jiménez-Aguilera
author_facet Marta Ortega-Ortega
Roberto Montero-Granados
Juan de Dios Jiménez-Aguilera
author_sort Marta Ortega-Ortega
collection DOAJ
description Objective: To estimate differences in the economic valuation and sociodemographic and clinical factors associated with informal care between phases of the treatment in the case of blood cancer patients. Methods: 139 haematological cancer patients who underwent a stem cell transplantation completed a longitudinal questionnaire according to 3 phases of the treatment: short-term (pre-transplant), medium-term (1st year post-transplant) and long-term (2nd-6th year post-transplant). Economic value of informal care was estimated using proxy good and opportunity cost methods. Ordered and binary logistic models were performed to identify factors associated with informal care. Results: 123 patients reported having received informal care. A progressive reduction of the number of hours of care was observed between phases. Monetary value per patient ranged from 1,288 to 3,409; 1,045 to 2,786; and 336 to 854 €/month in the short, medium and long term, respectively. Patients with acute leukaemia and those who received an unrelated allogeneic transplantation were 22% (short-term) and 33.5% (medium-term) more likely to receive more than 8 hours/day of care respect to patients diagnosed with lymphoma and autologous transplantation. In the long term, patients with multiple myeloma were more likely to receive more care. Better health status and higher educational level were associated with fewer daily hours of care. Conclusions: Informal care varies greatly between stages of the treatment depending on the clinical and sociodemographic factors. Significant caring time and societal costs are associated with such care in blood cancer patients. Resumen: Objetivo: Estimar los factores sociodemográficos y clínicos asociados al cuidado informal a lo largo de las diferentes etapas del tratamiento y su valoración económica en pacientes con neoplasia hematológica. Métodos: 139 pacientes oncohematológicos que recibieron un trasplante de células madre respondieron un cuestionario longitudinal basado en tres fases del tratamiento: corto, medio y largo plazo. Los cuidados informales recibidos se valoraron económicamente mediante los métodos del bien más próximo y coste de oportunidad. Se estimaron modelos de regresión logística ordenada y binaria para identificar factores asociados al cuidado informal. Resultados: 123 pacientes recibieron cuidado informal, con una reducción progresiva del número de horas a lo largo del tiempo. El valor monetario del cuidado informal recibido por paciente fue de 1288-3409 €, 1045-2786 € y 336-854 €/mes en el corto, medio y largo plazo, respectivamente. Los/las pacientes con leucemia aguda y los/las que recibieron un trasplante alogénico no emparentado tuvieron un 22% (corto plazo) y un 33,5% (medio plazo) más probabilidad de recibir >8 horas al día de cuidado respecto a los/las pacientes diagnosticados/as de linfoma y trasplante autólogo. A largo plazo, los/las pacientes con mieloma múltiple fueron más proclives a recibir más atención. Un mejor estado de salud y un mayor nivel de estudios se asociaron a menos horas diarias de cuidado. Conclusiones: Existe gran variación en el tiempo, el valor monetario y los factores asociados al cuidado informal en pacientes con neoplasia hematológica a lo largo de las distintas etapas del tratamiento. Keywords: Costs and cost analysis, Caregivers, Hematologic neoplasms, Socioeconomic factors, Palabras clave: Costes y análisis de costes, Cuidadores, Neoplasias hematológicas, Factores socioeconómicos
first_indexed 2024-12-23T02:00:49Z
format Article
id doaj.art-41b6b8054be843e6bef2599e3a464e87
institution Directory Open Access Journal
issn 0213-9111
language English
last_indexed 2024-12-23T02:00:49Z
publishDate 2018-09-01
publisher Elsevier
record_format Article
series Gaceta Sanitaria
spelling doaj.art-41b6b8054be843e6bef2599e3a464e872022-12-21T18:04:00ZengElsevierGaceta Sanitaria0213-91112018-09-01325411417Differences in the economic valuation and determining factors of informal care over time: the case of blood cancerMarta Ortega-Ortega0Roberto Montero-Granados1Juan de Dios Jiménez-Aguilera2Corresponding author.; Applied Economic Department, School of Economic and Business, University of Granada, Granada, SpainApplied Economic Department, School of Economic and Business, University of Granada, Granada, SpainApplied Economic Department, School of Economic and Business, University of Granada, Granada, SpainObjective: To estimate differences in the economic valuation and sociodemographic and clinical factors associated with informal care between phases of the treatment in the case of blood cancer patients. Methods: 139 haematological cancer patients who underwent a stem cell transplantation completed a longitudinal questionnaire according to 3 phases of the treatment: short-term (pre-transplant), medium-term (1st year post-transplant) and long-term (2nd-6th year post-transplant). Economic value of informal care was estimated using proxy good and opportunity cost methods. Ordered and binary logistic models were performed to identify factors associated with informal care. Results: 123 patients reported having received informal care. A progressive reduction of the number of hours of care was observed between phases. Monetary value per patient ranged from 1,288 to 3,409; 1,045 to 2,786; and 336 to 854 €/month in the short, medium and long term, respectively. Patients with acute leukaemia and those who received an unrelated allogeneic transplantation were 22% (short-term) and 33.5% (medium-term) more likely to receive more than 8 hours/day of care respect to patients diagnosed with lymphoma and autologous transplantation. In the long term, patients with multiple myeloma were more likely to receive more care. Better health status and higher educational level were associated with fewer daily hours of care. Conclusions: Informal care varies greatly between stages of the treatment depending on the clinical and sociodemographic factors. Significant caring time and societal costs are associated with such care in blood cancer patients. Resumen: Objetivo: Estimar los factores sociodemográficos y clínicos asociados al cuidado informal a lo largo de las diferentes etapas del tratamiento y su valoración económica en pacientes con neoplasia hematológica. Métodos: 139 pacientes oncohematológicos que recibieron un trasplante de células madre respondieron un cuestionario longitudinal basado en tres fases del tratamiento: corto, medio y largo plazo. Los cuidados informales recibidos se valoraron económicamente mediante los métodos del bien más próximo y coste de oportunidad. Se estimaron modelos de regresión logística ordenada y binaria para identificar factores asociados al cuidado informal. Resultados: 123 pacientes recibieron cuidado informal, con una reducción progresiva del número de horas a lo largo del tiempo. El valor monetario del cuidado informal recibido por paciente fue de 1288-3409 €, 1045-2786 € y 336-854 €/mes en el corto, medio y largo plazo, respectivamente. Los/las pacientes con leucemia aguda y los/las que recibieron un trasplante alogénico no emparentado tuvieron un 22% (corto plazo) y un 33,5% (medio plazo) más probabilidad de recibir >8 horas al día de cuidado respecto a los/las pacientes diagnosticados/as de linfoma y trasplante autólogo. A largo plazo, los/las pacientes con mieloma múltiple fueron más proclives a recibir más atención. Un mejor estado de salud y un mayor nivel de estudios se asociaron a menos horas diarias de cuidado. Conclusiones: Existe gran variación en el tiempo, el valor monetario y los factores asociados al cuidado informal en pacientes con neoplasia hematológica a lo largo de las distintas etapas del tratamiento. Keywords: Costs and cost analysis, Caregivers, Hematologic neoplasms, Socioeconomic factors, Palabras clave: Costes y análisis de costes, Cuidadores, Neoplasias hematológicas, Factores socioeconómicoshttp://www.sciencedirect.com/science/article/pii/S0213911117300948
spellingShingle Marta Ortega-Ortega
Roberto Montero-Granados
Juan de Dios Jiménez-Aguilera
Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer
Gaceta Sanitaria
title Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer
title_full Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer
title_fullStr Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer
title_full_unstemmed Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer
title_short Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer
title_sort differences in the economic valuation and determining factors of informal care over time the case of blood cancer
url http://www.sciencedirect.com/science/article/pii/S0213911117300948
work_keys_str_mv AT martaortegaortega differencesintheeconomicvaluationanddeterminingfactorsofinformalcareovertimethecaseofbloodcancer
AT robertomonterogranados differencesintheeconomicvaluationanddeterminingfactorsofinformalcareovertimethecaseofbloodcancer
AT juandediosjimenezaguilera differencesintheeconomicvaluationanddeterminingfactorsofinformalcareovertimethecaseofbloodcancer